Mar 1, 2026 Log in

News

【SCI Pharmtech】March 2026 Revenue NT$128 Million (YoY -24.4%)

Citation-Grade Primary-source linked Schema.org verified NQ 4 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 1, 2026 1:10 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

SCI Pharmtech's revenue for March 2026 was NT$128 million, a decrease of 24.4% year-over-year.
The company is in the Biotechnology and Medical Care industry.

SCI Pharmtech's revenue for March 2026 was NT$128 million, a decrease of 24.4% year-over-year. The company is in the Biotechnology and Medical Care industry.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-4119-11503 Distributor: PR Times
Published: Mar 1, 2026

Company Ticker: 4119 Company Name: SCI Pharmtech Industry: Biotechnology and Medical Care Data Month: 2026-03 Monthly Revenue: 127,606 thousand TWD (128 million) Year-over-Year Change: -24.4%

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-03

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　Apr 12, 2026 4:30 PM
AI structured & analyzed　Apr 12, 2026 9:27 PM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

How was SCI Pharmtech's revenue in March 2026?

It was TWD 128 million, a sharp decline of 24.4% year-over-year.

What kind of company is SCI Pharmtech?

It is a company that develops and manufactures active pharmaceutical ingredients (APIs) for pharmaceutical companies.

Why did SCI Pharmtech's revenue decrease significantly?

The likely reasons include a temporary decrease in orders from its pharmaceutical clients or a lack of shipments for certain products.

Cite this article — HOW TO CITE

Washin AI News Desk“【SCI Pharmtech】March 2026 Revenue NT$128 Million (YoY -24.4%)”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E6%97%AD%E5%AF%8C/en/news/2026-03-01-sci-pharmtech-march-2026-revenue-nt-128

AI CRAWLER ACTIVITY

as of Aug 18, 2026

AI crawler visits to this article (cumulative)213 bots

Site-wide cumulative

Applebot

bot_visits_summary

2837k

last Aug 18, 2026

GPTBot

bot_visits_summary

2063k

last Aug 17, 2026

ClaudeBot

bot_visits_summary

796k

last Aug 18, 2026

Bingbot

bot_visits_summary

771k

last Aug 18, 2026

Amazonbot

bot_visits_summary

620k

last Aug 18, 2026

Meta AI

bot_visits_summary

479k

last Aug 18, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 旭富 Back to newsroom (49)

Copied